• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预后营养指数对肺鸟分枝杆菌复合体病患者结局的影响。

Impact of prognostic nutritional index on outcomes in patients with Mycobacterium avium complex pulmonary disease.

机构信息

Division of Pulmonology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.

Institute of Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Republic of Korea.

出版信息

PLoS One. 2020 May 6;15(5):e0232714. doi: 10.1371/journal.pone.0232714. eCollection 2020.

DOI:10.1371/journal.pone.0232714
PMID:32374770
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7202629/
Abstract

Onodera's prognostic nutritional index (PNI) is useful in predicting prognosis of various diseases. But the usefulness of PNI in non-surgical patients has not been sufficiently proven yet. In patients with mycobacterium avium complex pulmonary disease (MAC-PD), malnutrition is an important factor that affects the quality of life and morbidity. Here, we aimed to evaluate whether PNI is related with clinical outcomes in MAC-PD patients. We examined 663 patients diagnosed with MAC-PD between May 2005 and November 2017. PNI score was calculated at the time of diagnosis and treatment initiation, and patients were divided into malnutrition and non-malnutrition groups according to a cut-off PNI score of 45. As the recommended duration of treatment for MAC-PD is 12 months following sputum conversion, treatment duration less than 12 months was defined as treatment intolerance. Survivals were compared with the log-rank test. Multivariate logistic regression and multivariate Cox proportional hazards models were used to estimate the odds ratio (OR) and hazards ratio (HR) for treatment intolerance and mortality, respectively. Of the 306 patients that received treatment, 193 received treatment longer than 12 months. In the multivariable logistic regression model, malnutrition at the time of treatment initiation was related with treatment intolerance (OR: 2.559, 95% confidence interval [CI]: 1.414-4.634, P = 0.002). Patients in the malnutrition group at the time of diagnosis exhibited lower survival (P<0.001) and malnutrition at the time of diagnosis was a significant risk for all-cause mortality (HR: 2.755, 95% CI: 1.610-4.475, P<0.001). Malnutrition, as defined by PNI, is an independent predictor for treatment intolerance and all-cause mortality in patients with MAC-PD.

摘要

小野寺预后营养指数(PNI)可用于预测多种疾病的预后。但是,PNI 在非手术患者中的有效性尚未得到充分证明。在分枝杆菌复合群肺病(MAC-PD)患者中,营养不良是影响生活质量和发病率的重要因素。在这里,我们旨在评估 PNI 是否与 MAC-PD 患者的临床结局相关。我们检查了 2005 年 5 月至 2017 年 11 月期间诊断为 MAC-PD 的 663 例患者。在诊断和治疗开始时计算 PNI 评分,并根据 45 的 PNI 评分截断值将患者分为营养不良和非营养不良组。由于 MAC-PD 的推荐治疗时间为痰转化后 12 个月,因此将治疗时间少于 12 个月定义为治疗不耐受。采用对数秩检验比较生存率。使用多变量逻辑回归和多变量 Cox 比例风险模型分别估计治疗不耐受和死亡率的比值比(OR)和风险比(HR)。在接受治疗的 306 例患者中,有 193 例接受治疗时间超过 12 个月。在多变量逻辑回归模型中,治疗开始时的营养不良与治疗不耐受相关(OR:2.559,95%置信区间[CI]:1.414-4.634,P = 0.002)。诊断时营养不良的患者生存时间较低(P<0.001),诊断时营养不良是全因死亡率的显著危险因素(HR:2.755,95%CI:1.610-4.475,P<0.001)。PNI 定义的营养不良是 MAC-PD 患者治疗不耐受和全因死亡率的独立预测因子。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a26e/7202629/6cbb81bb1d27/pone.0232714.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a26e/7202629/f9c2a7e77632/pone.0232714.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a26e/7202629/6cbb81bb1d27/pone.0232714.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a26e/7202629/f9c2a7e77632/pone.0232714.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a26e/7202629/6cbb81bb1d27/pone.0232714.g002.jpg

相似文献

1
Impact of prognostic nutritional index on outcomes in patients with Mycobacterium avium complex pulmonary disease.预后营养指数对肺鸟分枝杆菌复合体病患者结局的影响。
PLoS One. 2020 May 6;15(5):e0232714. doi: 10.1371/journal.pone.0232714. eCollection 2020.
2
Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease.影响鸟分枝杆菌复合群肺病患者痰菌转阴及治疗结果的因素。
J Microbiol Immunol Infect. 2007 Aug;40(4):342-8.
3
Long-Term Prognosis and Antimycobacterial Glycolipid Antibody as Biomarker in Mycobacterium avium-intracellulare Complex Pulmonary Disease.抗酸分枝杆菌糖脂抗体作为鸟分枝杆菌胞内复合体肺病的生物标志物与长期预后的关系。
Microbiol Spectr. 2022 Jun 29;10(3):e0053022. doi: 10.1128/spectrum.00530-22. Epub 2022 Apr 25.
4
Retrospective study of the predictors of mortality and radiographic deterioration in 782 patients with nodular/bronchiectatic Mycobacterium avium complex lung disease.对782例结节性/支气管扩张型鸟分枝杆菌复合群肺病患者的死亡率和影像学恶化预测因素的回顾性研究。
BMJ Open. 2015 Aug 5;5(8):e008058. doi: 10.1136/bmjopen-2015-008058.
5
Effective treatment for clarithromycin-resistant Mycobacterium avium complex lung disease.克拉霉素耐药鸟分枝杆菌复合群肺病的有效治疗方法。
J Infect Chemother. 2020 Jul;26(7):676-680. doi: 10.1016/j.jiac.2020.02.008. Epub 2020 Mar 11.
6
Development and validation of a prognostic scoring model for Mycobacterium avium complex lung disease: an observational cohort study.鸟分枝杆菌复合群肺病预后评分模型的开发与验证:一项观察性队列研究
BMC Infect Dis. 2017 Jun 19;17(1):436. doi: 10.1186/s12879-017-2544-0.
7
Natural history of complex lung disease in untreated patients with stable course.未经治疗的稳定期患者复杂肺部疾病的自然史。
Eur Respir J. 2017 Mar 8;49(3). doi: 10.1183/13993003.00537-2016. Print 2017 Mar.
8
Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease.克拉霉素耐药鸟分枝杆菌复合群肺病的药物治疗结果分析
BMC Infect Dis. 2016 Jan 27;16:31. doi: 10.1186/s12879-016-1384-7.
9
Mycobacterium avium Complex: Addressing Gaps in Diagnosis and Management.鸟分枝杆菌复合群:解决诊断和管理方面的差距。
J Infect Dis. 2020 Aug 20;222(Suppl 4):S199-S211. doi: 10.1093/infdis/jiaa354.
10
Effect of sputum quality on Mycobacterium avium-intracellulare complex lung disease diagnosis and treatment initiation according to disease type.痰液质量对不同类型鸟分枝杆菌复合群肺病诊断及开始治疗的影响
Diagn Microbiol Infect Dis. 2022 Nov;104(3):115773. doi: 10.1016/j.diagmicrobio.2022.115773. Epub 2022 Jul 22.

引用本文的文献

1
BACES score: a predictor of health-related quality of life and associated factors in patients with nontuberculous mycobacterial pulmonary disease.BACES评分:非结核分枝杆菌肺病患者健康相关生活质量的预测指标及相关因素
Sci Rep. 2025 Jul 19;15(1):26257. doi: 10.1038/s41598-025-09971-3.
2
Protein-energy restriction-induced lipid metabolism disruption causes stable-to-progressive disease shift in Mycobacterium avium-infected female mice.蛋白质能量限制诱导的脂代谢紊乱导致感染鸟分枝杆菌的雌性小鼠疾病从稳定期向进展期转变。
EBioMedicine. 2024 Jul;105:105198. doi: 10.1016/j.ebiom.2024.105198. Epub 2024 Jun 17.
3
Treatable traits and challenges in the clinical management of non-tuberculous mycobacteria lung disease in people with cystic fibrosis.

本文引用的文献

1
Treatment of Complex Pulmonary Disease.复杂肺部疾病的治疗
Tuberc Respir Dis (Seoul). 2019 Jan;82(1):15-26. doi: 10.4046/trd.2018.0060.
2
Usefulness of the preoperative prognostic nutritional index score as a predictor of the outcomes of lung transplantation: A single-institution experience.术前预后营养指数评分作为肺移植结局预测指标的实用性:单中心经验。
Clin Nutr. 2019 Oct;38(5):2423-2429. doi: 10.1016/j.clnu.2018.10.027. Epub 2018 Nov 10.
3
Prognostic Nutritional Index: an easy nutritional screening for patients with head and neck cancer?
囊性纤维化患者中非结核分枝杆菌肺病的临床管理中可治疗的特征和挑战。
Respir Res. 2023 Dec 16;24(1):316. doi: 10.1186/s12931-023-02612-1.
4
A Systematic Review of Factors Associated with Mortality among Patients with Complex Lung Disease.复杂肺部疾病患者死亡率相关因素的系统评价
Pathogens. 2023 Nov 8;12(11):1331. doi: 10.3390/pathogens12111331.
5
Association between nutritional status scores and the 30-day mortality in patients with acute kidney injury: an analysis of MIMIC-III database.营养状况评分与急性肾损伤患者 30 天死亡率的关系:对 MIMIC-III 数据库的分析。
BMC Nephrol. 2023 Oct 6;24(1):296. doi: 10.1186/s12882-023-03329-5.
6
Myosteatosis as a prognostic factor of Mycobacterium avium complex pulmonary disease.肌肉脂肪浸润作为鸟分枝杆菌复合体肺病的预后因素。
Sci Rep. 2023 Aug 22;13(1):13680. doi: 10.1038/s41598-023-40984-y.
7
The factors associated with mortality and progressive disease of nontuberculous mycobacterial lung disease: a systematic review and meta-analysis.非结核分枝杆菌肺病患者的死亡和疾病进展的相关因素:系统评价和荟萃分析。
Sci Rep. 2023 May 5;13(1):7348. doi: 10.1038/s41598-023-34576-z.
8
Onodera's prognostic nutritional index: Comparison of its role in the severity and outcomes of patients with COVID‑19 during the periods of alpha, delta and omicron variant predominance.小野寺预后营养指数:比较其在新冠病毒α、δ和奥密克戎变异株流行期间对新冠肺炎患者严重程度和预后的作用。
Exp Ther Med. 2022 Sep 16;24(5):675. doi: 10.3892/etm.2022.11611. eCollection 2022 Nov.
9
Can prognostic nutritional index predict mortality in intensive care patients with COVID-19?预后营养指数能否预测 COVID-19 重症监护患者的死亡率?
Int J Clin Pract. 2021 Nov;75(11):e14800. doi: 10.1111/ijcp.14800. Epub 2021 Sep 12.
10
A Low Body Mass Index Is Associated with Unsuccessful Treatment in Patients with Complex Pulmonary Disease.低体重指数与复杂肺部疾病患者治疗失败相关。
J Clin Med. 2021 Apr 8;10(8):1576. doi: 10.3390/jcm10081576.
预后营养指数:一种用于头颈癌患者的简易营养筛查方法?
ESMO Open. 2018 Oct 24;3(6):e000449. doi: 10.1136/esmoopen-2018-000449. eCollection 2018.
4
Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement.非结核分枝杆菌肺病的治疗结局定义:一份非结核分枝杆菌网络共识声明
Eur Respir J. 2018 Mar 22;51(3). doi: 10.1183/13993003.00170-2018. Print 2018 Mar.
5
All About the Albumin? Prognostic Capacity of Serum Albumin in Patients With Treated HIV Infection.关于白蛋白?血清白蛋白在接受治疗的HIV感染患者中的预后能力。
J Infect Dis. 2018 Jan 17;217(3):347-349. doi: 10.1093/infdis/jix463.
6
Controlling Nutritional Status (CONUT) score is a prognostic marker for gastric cancer patients after curative resection.控制营养状况(CONUT)评分是胃癌患者根治性切除术后的预后标志物。
Gastric Cancer. 2018 Mar;21(2):204-212. doi: 10.1007/s10120-017-0744-3. Epub 2017 Jun 27.
7
Glasgow Prognostic Score predicts prognosis of intrahepatic cholangiocarcinoma.格拉斯哥预后评分可预测肝内胆管癌的预后。
Mol Clin Oncol. 2017 Apr;6(4):566-574. doi: 10.3892/mco.2017.1166. Epub 2017 Feb 16.
8
Distribution and clinical significance of Mycobacterium avium complex species isolated from respiratory specimens.从呼吸道标本中分离出的鸟分枝杆菌复合群菌种的分布及临床意义
Diagn Microbiol Infect Dis. 2017 Jun;88(2):125-137. doi: 10.1016/j.diagmicrobio.2017.02.017. Epub 2017 Mar 2.
9
Natural history of complex lung disease in untreated patients with stable course.未经治疗的稳定期患者复杂肺部疾病的自然史。
Eur Respir J. 2017 Mar 8;49(3). doi: 10.1183/13993003.00537-2016. Print 2017 Mar.
10
Characteristics associated with progression in patients with of nontuberculous mycobacterial lung disease : a prospective cohort study.非结核分枝杆菌肺病患者病情进展的相关特征:一项前瞻性队列研究。
BMC Pulm Med. 2017 Jan 5;17(1):5. doi: 10.1186/s12890-016-0349-3.